ES2153565T3 - Procedimiento y compuestos para la deteccion de analitos mediante medicion de la remanencia, y su utilizacion. - Google Patents

Procedimiento y compuestos para la deteccion de analitos mediante medicion de la remanencia, y su utilizacion.

Info

Publication number
ES2153565T3
ES2153565T3 ES96905824T ES96905824T ES2153565T3 ES 2153565 T3 ES2153565 T3 ES 2153565T3 ES 96905824 T ES96905824 T ES 96905824T ES 96905824 T ES96905824 T ES 96905824T ES 2153565 T3 ES2153565 T3 ES 2153565T3
Authority
ES
Spain
Prior art keywords
remanence
procedure
measuring
detection
analyzes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96905824T
Other languages
English (en)
Spanish (es)
Inventor
Werner Weitschies
Roman Kotitz
Lutz Trahms
Thomas Bunte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2153565T3 publication Critical patent/ES2153565T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • G01N33/54333Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/80Fluorescent dyes, e.g. rhodamine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES96905824T 1995-03-01 1996-02-29 Procedimiento y compuestos para la deteccion de analitos mediante medicion de la remanencia, y su utilizacion. Expired - Lifetime ES2153565T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19508772A DE19508772C2 (de) 1995-03-01 1995-03-01 Verfahren und Verbindungen zur Detektion von Analyten mittels Remanenzmessung und deren Verwendung

Publications (1)

Publication Number Publication Date
ES2153565T3 true ES2153565T3 (es) 2001-03-01

Family

ID=7756385

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96905824T Expired - Lifetime ES2153565T3 (es) 1995-03-01 1996-02-29 Procedimiento y compuestos para la deteccion de analitos mediante medicion de la remanencia, y su utilizacion.

Country Status (23)

Country Link
US (1) US7033841B1 (enExample)
EP (1) EP0812422B1 (enExample)
JP (1) JP3628704B2 (enExample)
KR (1) KR100416186B1 (enExample)
CN (1) CN1144048C (enExample)
AT (1) ATE197507T1 (enExample)
AU (1) AU706804B2 (enExample)
CA (1) CA2214267A1 (enExample)
DE (2) DE19508772C2 (enExample)
DK (1) DK0812422T3 (enExample)
ES (1) ES2153565T3 (enExample)
FI (1) FI973561A7 (enExample)
GR (1) GR3035495T3 (enExample)
HU (1) HU221384B1 (enExample)
IL (1) IL117201A (enExample)
MX (1) MX9706437A (enExample)
NO (1) NO974000L (enExample)
NZ (1) NZ303196A (enExample)
PT (1) PT812422E (enExample)
RU (1) RU2175136C2 (enExample)
UA (1) UA51646C2 (enExample)
WO (1) WO1996027133A1 (enExample)
ZA (1) ZA961704B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615254C2 (de) * 1996-04-18 1999-03-11 Diagnostikforschung Inst Gerät zur höchstempfindlichen magnetischen Detektion von Analyten
US6592820B1 (en) * 1998-11-05 2003-07-15 Bio-Spectrum Technologies, Inc. System and method for biochemical assay
JP2001147230A (ja) * 1999-11-19 2001-05-29 Hitachi Software Eng Co Ltd バイオチップ読取装置及び標識試薬
JP3962385B2 (ja) 2004-03-11 2007-08-22 株式会社日立製作所 免疫検査装置及び免疫検査方法
JP4347107B2 (ja) * 2004-03-26 2009-10-21 株式会社イノアックコーポレーション 磁気的免疫反応測定のための試験容器およびその製造方法
US8217647B2 (en) * 2006-12-19 2012-07-10 Koninklijke Philips Electronics N.V. Measuring agglutination parameters
KR100863153B1 (ko) * 2007-02-15 2008-10-13 엘지마이크론 주식회사 질병 진단용 바이오 센서 및 카트리지와 이를 이용한 질병진단 시스템
CN101918842A (zh) * 2007-11-20 2010-12-15 3M创新有限公司 利用含二乙炔的聚合物传感器分析细菌样品的方法
DE102008013997B4 (de) 2008-03-13 2012-10-31 Bundesrepublik Deutschland, vertr. durch d. Bundesministerium f. Wirtschaft und Technologie, dieses vertreten durch d. Präsidenten d. Physikalisch-Technischen Bundesanstalt Verfahren zum quantitativen Nachweis von Analyten in flüssigem Medium
DE102008057081A1 (de) * 2008-11-13 2010-05-20 Siemens Aktiengesellschaft Vorrichtung und Verfahren zur Bestimmung der Menge ferromagnetischer Partikel in einer Suspension
RU2528885C2 (ru) * 2011-10-04 2014-09-20 Общество с ограниченной ответственностью "Инноград Пущино" Способ детекции аналита из раствора на частицах и устройство для его реализации
CN105102979B (zh) * 2013-01-29 2017-05-03 生物辐射海法有限公司 利用磁性纳米粒子的检测测定法
CN108333536B (zh) * 2017-01-20 2021-11-19 国家纳米科学中心 基于纵向弛豫时间信号读出的磁传感器及其构建方法、用途

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1156795A (en) 1979-04-11 1983-11-08 Richard G. Newell Curable fluorocarbon substituted polyetherurethaneacrylates
FR2461521A1 (fr) * 1979-07-20 1981-02-06 Anvar Fluides magnetiques, notamment ferrofluides, et procede pour leur obtention
CA1235856A (en) 1983-03-23 1988-05-03 Reiho Takabe Biocompatible composite material
EP0180384B1 (en) * 1984-11-01 1991-04-24 TECHNICON INSTRUMENTS CORPORATION(a Delaware corporation) Magnetically responsive reagent carrier and method of preparation
US4824587A (en) * 1985-03-18 1989-04-25 The Dow Chemical Company Composites of coercive particles and superparamagnetic particles
US4849210A (en) * 1985-05-08 1989-07-18 Molecular Biosystems, Inc. Magnetic resonance imaging of liver and spleen with superparamagnetic contrast agents
WO1987001040A1 (en) 1985-08-23 1987-02-26 Washington Research Foundation Polymeric intraocular lens material having improved surface properties
US5597531A (en) * 1985-10-04 1997-01-28 Immunivest Corporation Resuspendable coated magnetic particles and stable magnetic particle suspensions
IT1190428B (it) 1985-12-05 1988-02-16 Ausimont Spa Poliesteri fluorurati
US4661408A (en) * 1986-03-18 1987-04-28 E.I. Du Pont De Nemours And Company Coated chromium dioxide particles
US4724390A (en) * 1986-03-24 1988-02-09 Rauscher Elizabeth A Non-superconducting apparatus for detecting magnetic and electromagnetic fields
US5100689A (en) 1987-04-10 1992-03-31 University Of Florida Surface modified surgical instruments, devices, implants, contact lenses and the like
US4913883A (en) * 1987-07-20 1990-04-03 Hitachi, Ltd. Particle agglutination immunoassay apparatus
FR2620624B1 (fr) 1987-09-23 1993-08-20 Irap Article en materiau polymere, modifie en surface pour presenter une hemocompatibilite amelioree et une thrombogeneicite diminuee, et son procede d'obtention
JPH0235774A (ja) * 1988-07-26 1990-02-06 Matsushita Electric Ind Co Ltd 半導体装置
JP2938918B2 (ja) * 1990-01-25 1999-08-25 ティーディーケイ株式会社 磁気微粒子の粒度測定方法
GB9007408D0 (en) * 1990-04-02 1990-05-30 Nycomed As Compositions
US5164297A (en) * 1990-05-03 1992-11-17 Advanced Magnetics Inc. Solvent mediated relaxation assay system
IL98744A0 (en) * 1990-07-06 1992-07-15 Gen Hospital Corp Method of studying biological tissue using monocrystalline particles
FR2669226B1 (fr) 1990-11-21 1997-01-03 Irap Dispositif a usage ophtalmologique forme d'un substrat polymerique comportant des groupements fluores en surface, et procede d'obtention.
DE4117782C2 (de) * 1991-05-28 1997-07-17 Diagnostikforschung Inst Nanokristalline magnetische Eisenoxid-Partikel, Verfahren zu ihrer Herstellung sowie diagnostische und/oder therapeutische Mittel
US5464696A (en) * 1992-08-13 1995-11-07 Bracco International B.V. Particles for NMR imaging
DE4309333A1 (de) * 1993-03-17 1994-09-22 Silica Gel Gmbh Superparamagnetische Teilchen, Verfahren zu ihrer Herstellung und Verwendung derselben
CA2147813A1 (en) 1994-04-28 1995-10-29 Richard Dixon Intravascular prosthesis with anti-thrombogenic coating
US5700559A (en) 1994-12-16 1997-12-23 Advanced Surface Technology Durable hydrophilic surface coatings
DE19503664C2 (de) * 1995-01-27 1998-04-02 Schering Ag Magnetorelaxometrische Detektion von Analyten
DE19514104C2 (de) 1995-04-13 1997-05-28 Behringwerke Ag Beschichtung für in den Blutstrom oder in das Gewebe des menschlichen Körpers einbringbares Biomaterial
US5609629A (en) 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
DE19535729A1 (de) 1995-09-26 1997-03-27 Huels Chemische Werke Ag Mikroorganismenabweisende Oberflächen

Also Published As

Publication number Publication date
UA51646C2 (uk) 2002-12-16
RU2175136C2 (ru) 2001-10-20
ZA961704B (enExample) 1996-07-29
DE19508772A1 (de) 1996-09-05
CN1177401A (zh) 1998-03-25
ATE197507T1 (de) 2000-11-11
DE19508772C2 (de) 1998-01-29
JPH11508031A (ja) 1999-07-13
IL117201A (en) 2000-11-21
AU4943496A (en) 1996-09-18
HUP9800225A3 (en) 1999-03-01
WO1996027133A1 (de) 1996-09-06
KR19980702665A (ko) 1998-08-05
HUP9800225A2 (hu) 1998-04-28
PT812422E (pt) 2001-03-30
GR3035495T3 (en) 2001-05-31
NO974000D0 (no) 1997-09-01
HU221384B1 (en) 2002-09-28
EP0812422A1 (de) 1997-12-17
JP3628704B2 (ja) 2005-03-16
MX9706437A (es) 1997-11-29
NO974000L (no) 1997-09-01
KR100416186B1 (ko) 2004-03-18
US7033841B1 (en) 2006-04-25
DE59606129D1 (de) 2000-12-14
NZ303196A (en) 1999-04-29
AU706804B2 (en) 1999-06-24
CA2214267A1 (en) 1996-09-06
CN1144048C (zh) 2004-03-31
IL117201A0 (en) 1996-06-18
FI973561A0 (fi) 1997-08-29
FI973561L (fi) 1997-08-29
FI973561A7 (fi) 1997-08-29
DK0812422T3 (da) 2001-01-29
EP0812422B1 (de) 2000-11-08

Similar Documents

Publication Publication Date Title
ES2153565T3 (es) Procedimiento y compuestos para la deteccion de analitos mediante medicion de la remanencia, y su utilizacion.
BR0215405A (pt) Composições e processos de uso de collajolie
NO944430L (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
ES2142569T3 (es) Procedimientos y compuestos para la deteccion magneto-relaxometrica de analitos y su utilizacion.
BR9608032A (pt) Sulfonamidas contendo thf inibidoras de aspartil protease
FI20012510L (fi) Fenyyliheterosyklejä syklo-oksigenaasi-2-inhibiittoreina
DZ2285A1 (fr) Inhibiteurs de protéase de la cystéine.
DE69016371D1 (de) Nitrotriazalon enthaltende gaserzeugende Zusammensetzungen.
BR0317715A (pt) Composições e processos de uso de collajolie
AR063780A2 (es) Un anticuerpo aislado composicion farmaceutica que lo comprende y metodo para inhibir la actividad de y detectar una interleuquina
DE4499925T1 (de) Abspülbare Zusammensetzungen
EA199900373A2 (ru) Фармацевтические композиции
FR2676173B1 (fr) Composition cosmetique contenant un agent alcalinisant sans odeur.
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
CO5180587A1 (es) Composicion farmaceutica de orlistat que contiene tensoactivos y dispersantes
ES2170918T3 (es) Inhibidor de proteina quinasa c sustituidos con halo.
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
EA200200798A1 (ru) Кальцилитические соединения
NO913716D0 (no) Teflon-sproeytenaalsett for engangsbruk.
FR2705038B1 (fr) Integrateur de liquides.
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
ITTO950808A0 (it) Composizione di aerosol per uso alimentare.
ES1025932Y (es) Dispositivo para cerrar hermeticamente recipientes.
ES1021294Y (es) Muneco de doble uso.
ES242839Y (es) Colgante perfumador de uso personal.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 812422

Country of ref document: ES